Remove tag patient-centricity
article thumbnail

September 30, 2022: CTTI’s Digital Health Trials Hub Recommendations and Resources to Run Your Digital Health Trial (Marianne Chase, MGH, CTTI Team Lead, Jörg Goldhahn, ETH Zurich, CTTI Team Lead)

Rethinking Clinical Trials

The Clinical Trial Transformation Initiative (CTTI) envisions an evidence generating system with trials that are patient-centered, integrated into health processes, quality, leverage all available data, and improve population health. We need to work together to find ways to evaluate the potential benefits and share lessons learned broadly.

Trials 130
article thumbnail

What can pharma marketing learn from other regulated industries?

pharmaphorum

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Virtual connections. Engagement channels. Regulated industry learnings.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Rare Disease Drugs and Research Advancements

XTalks

Skyclarys (omobaloxone) was approved in 2023 for the treatment of adults and pediatric patients 16 years of age and older with Friedreich’s ataxia, a rare, neurological disease​​. Sarepta hopes to clarify Elvidys’ effectiveness in older children in a confirmatory trial.

article thumbnail

What is modular content and why do pharma marketers need it NOW?

pharmaphorum

Robb DeFilippis, managing director, life sciences, for end-to-end global creative production and sourcing partner Tag in the Americas agrees. It can be used for sales, marketing and patient communication materials, in print or digital form.

article thumbnail

iOS 15 Update: Mail Privacy Protection

Intouch Solutions

In this POV, we evaluate the potential impact to the email channel and opportunities to continue to deliver ethical, quality email experiences and personalization for pharma customers, including healthcare providers (HCPs) and patients. The result? Lastly, marketers will be blocked from receiving forward tracking data. ©Intouch Group 2021.

article thumbnail

How data is crucial to the relaunch of the Cancer Moonshot

pharmaphorum

A key part of this initiative was the establishment of the Cancer Moonshot Biobank, which will ask cancer patients to donate biospecimens and associated health information to aid research. The objective is to gather patient biospecimens longitudinally to understand how patients react to treatments and how cancer develops over time.

article thumbnail

Life Sciences 2022 Year in Review

XTalks

This included greater adoption and acceptance of decentralized clinical trial models, emphasis on patient-centric approaches in trials, growing digitization of healthcare and dealing with drug manufacturing challenges. Gene Therapy Approvals. Manufacturer: Ferring Pharmaceuticals A/S. Manufacturer: bluebird bio, Inc.